In this antimicrobial resistance era, where resistance to most antibiotics is commonplace,
metals and metalloid based antimicrobials (MBA) have emerged as an alternative to treat …

We are now moving into the antimicrobial resistance (AMR) era where more antibiotic
resistant bacteria are now the majority, a problem brought on by both misuse and over use …

Metals have been used as antimicrobial agents since antiquity, but throughout most of
history their modes of action have remained unclear. Recent studies indicate that different …

The progression of antimicrobial resistance and the presence of microbial biofilms pose
serious threats, which have prompted the development of novel antimicrobials such as …

The introduction of antibiotics originated from the discovery of penicillin by Sir Alexander
Fleming in 1928, thus fueling a new medical era. 1 Antibiotics were once regarded as …

The mounting burden of antimicrobial resistance (AMR) is one of the most concerning
threats to public health worldwide. With low economic incentives and a dwindling supply of …

Metal based‐antimicrobials have potential for profiling sustainability solutions to infection
care and health; with biotechnological applications providing novel compounds. Yet they …

To address the mounting resistance challenge, novel antibiotics and unprecedented
mechanisms of action are urgently needed. In this context, metals have attracted attention in …

The increasing bacterial resistance caused by antibiotic overuse has promoted the search
for new antimicrobial strategies. Metals uptake via bacterial metallophores are studied to …

The occurrence of drug-resistant bacteria is drastically rising and new and effective antibiotic
classes are urgently needed. However, most of the compounds in development are minor …